Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Catheter Infusion in Kidney Transplant
NCT04786470Phase 3Unknown
- Sponsor
- Western University
- Start
- May 2021
- Primary completion
- Nov 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Western University. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04786470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786470.